Trial Profile
Contrast Enhanced Ultrasonography to Detect Human Renal Transplant Rejection
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Mar 2023
Price :
$35
*
At a glance
- Drugs Perflubutane (Primary)
- Indications Renal transplant rejection
- Focus Diagnostic use
- 02 Mar 2023 Status changed from recruiting to completed.
- 18 May 2021 Planned End Date changed from 30 May 2021 to 30 May 2023.
- 18 May 2021 Planned primary completion date changed from 30 May 2021 to 30 May 2022.